XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Apr. 01, 2017
Apr. 02, 2016
Cash flows from operating activities:    
Net loss $ (10,245) $ (29,065)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 42,683 42,904
Stock-based compensation 39,565 38,025
Excess tax benefits from stock-based awards (139) (56)
Non-cash portion of restructuring charges 260 0
Other non-cash items, net 479 204
Changes in operating assets and liabilities, excluding the effects of acquisitions:    
Accounts receivable 15,373 63,617
Accounts payable, accrued expenses and other current liabilities 11,183 (25,907)
Accrued compensation and benefits (51,769) 8,215
Deferred revenue 27,457 24,019
Accrued and deferred income taxes (14,680) (8,826)
Other current assets and prepaid expenses (11,424) (1,882)
Other noncurrent assets and liabilities (20,332) (1,109)
Net cash provided by operating activities 28,411 110,139
Cash flows from investing activities:    
Additions to property and equipment (14,789) (8,866)
Purchases of short- and long-term marketable securities (3,420) 0
Proceeds from sales and maturities of short- and long-term marketable securities 4,700 0
Acquisitions of businesses, net of cash acquired 0 (164,191)
Proceeds from sales of investments 15,218 0
Net cash provided by (used in) investing activities 1,709 (173,057)
Cash flows from financing activities:    
Borrowings 100,000 170,000
Repayments of borrowings under credit facility (140,000) 0
Proceeds from issuance of common stock 3,978 1
Excess tax benefits from stock-based awards 139 56
Credit facility origination costs (184) (1,050)
Contingent consideration (2,711) (1,250)
Payments of withholding taxes in connection with vesting of stock-based awards (19,166) (15,471)
Net cash provided by (used in) financing activities (57,944) 152,286
Effect of exchange rate changes on cash and cash equivalents (6,795) 5,671
Net increase (decrease) in cash and cash equivalents (34,619) 95,039
Cash and cash equivalents, beginning of period 277,935 273,417
Cash and cash equivalents, end of period $ 243,316 $ 368,456